About
Longevity Biotech develops precision therapies targeting neurodegenerative diseases using their Hybridtide™ platform and precision neuroscience approaches, including clinical trials for Parkinson's disease.
Explore Longevity Biotech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.